CLINICAL ROLE -
The Value of the Pharmacist in Treating COVID-19
Join expert faculty members as they discuss the vital role of pharmacists during the COVID-19 pandemic.
How Good Neighbor Pharmacies Are Tackling the COVID-19 Pandemic
Jennifer Zilka, group vice president of Good Neighbor Pharmacy field programs and services, discusses the role community pharmacies can play during the COVID-19 pandemic.
Evolving Models in Specialty Pharmacy
Thom Cohn, chief strategy officer, Asembia, discusses recent developments in specialty pharmacy models.
Preparing for COVID-19 Testing in Community Pharmacies
Nancy Lyons, BSPharm, MBA, CDE, chief pharmacist of McKesson Health Mart, discusses how community pharmacists can prepare for the expansion of COVID-19 testing.
Digital Tools for Pharmacies to Improve Patient Outcomes
Shivani Patel, RPh, SVP, Clinical Operations and Technology, Asembia discusses the organization's mission.
Acute Myeloid Leukemia Practice Pearls: Considerations for Formulary Decisions
Acute Myeloid Leukemia Practice Pearls: Key Points in Pathway Identification
IPOP Induction for Patients With AML
Impact of AML Outpatient Treatment on Quality of Life
Role of the Pharmacist in AML Outpatient Treatment
Inpatient Versus Outpatient Treatment in AML
Practice Pearl 2: Medical Utilization Evaluation of Patients With AML
Practice Pearl 2: Safety Precautions With AML Treatments
Practice Pearl 2: P&T Committee for AML Treatments
Practice Pearl 2: Inpatient and Outpatient Formulary Treatments for AML
Practice Pearl 1: Categorizing Patients for Treatment in AML
Practice Pearl 1: The Importance of Cytogenetic Results in AML
Practice Pearl 1: Diagnosing Acute Myeloid Leukemia
Risk Factors for the Development of AML
Overview of Acute Myeloid Leukemia
Achieving Interconnectivity for Better Patient Care
Shivani Patel, RPh, SVP, Clinical Operations and Technology, Asembia discusses the use of digital tools to better connect industry leaders and health care professionals.
The Effect of CAD/PAD on Patient Quality of Life
Insights: Experts Discuss Importance of CAD/PAD Management
The Future of CAD/PAD Management
The Importance of CAD/PAD Education
Experience With Anticoagulant Interchangeability
New Therapy Data: Guideline Implementation Delays
Antithrombotic Therapy: Bleeding Adverse Event Defined
Phase 3 COMPASS Trial Overview
Who Is at Increased Risk of CAD/PAD?
